REPRESENTATIVENESS OF THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM DATA - RECENT TRENDS IN CANCER MORTALITY-RATES

被引:86
|
作者
FREY, CM
MCMILLEN, MM
COWAN, CD
HORM, JW
KESSLER, LG
机构
[1] OPIN RES CORP,WASHINGTON,DC
[2] NATL CTR HLTH STAT,HYATTSVILLE,MD 20782
关键词
D O I
10.1093/jnci/84.11.872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mortality, incidence, and survival rates are the primary measures used by the National Cancer Institute (NCI) to monitor cancer in the United States. The Surveillance, Epidemiology, and End Results (SEER) data system collects data on all cancers diagnosed among residents in geographically defined populations, which comprise about 10% of the U.S. population. This data system is the major component of the NCI system for tracking these rates. Thus, it is important to assess the degree to which SEER data are representative of the entire U.S. population. Purpose: National data on mortality, but not on incidence or survival, are available from the National Center for Health Statistics. These data provide a census against which mortality data from the subset of the SEER regions may be compared. Methods: Multivariate regression analyses of age-adjusted mortality rates from 1975 to 1988, computed for the SEER areas and for the entire United States, were performed for race- and sex-specific data from 15 cancer sites. Representativeness was evaluated by testing for differences in trends and levels between the data from the U.S. population and those from the SEER Program. Results: Data from the SEER regions reflected the correct direction of trend for all sites, although some race-, sex-, and site-specific differences existed for the magnitude of the trends and levels of mortality when compared with data from the U.S. population. Conclusions: The demonstration that data from the SEER population do occasionally yield mortality rates that differ from those for the entire U.S. population suggests that data from the SEER coverage population are, in some cases, not representative of the greater U.S. population. Implications: This issue is of particular relevance to the interpretation of incidence measures, computed from the SEER data, for which there is no national data-base. Future efforts should be directed at a better understanding of how the SEER population differs from the U.S. population so that SEER rates can be adjusted to be more nationally representative.
引用
收藏
页码:872 / 877
页数:6
相关论文
共 50 条
  • [41] Using Surveillance Epidemiology and End Results data to explore breast cancer mortality trend in an underserved population of Alabama, USA
    Bae, Sejong
    Jackson, Bradford E.
    Ojha, Rohit P.
    Uhm, Minyong
    Fouad, Mona
    Partridge, Edward
    Singh, Karan P.
    20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), 2013, : 1980 - 1984
  • [42] Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program
    Cordero da Luz, Felipe Andres
    Nascimento, Camila Piqui
    da Costa Marinho, Eduarda
    Felicidade, Pollyana Junia
    Antonioli, Rafael Mathias
    de Araujo, Rogerio Agenor
    Barbosa Silva, Marcelo Jose
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis
    Thomas J. O’Keefe
    Anne M. Wallace
    Breast Cancer Research and Treatment, 2020, 182 : 761 - 762
  • [44] Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program
    Felipe Andrés Cordero da Luz
    Camila Piqui Nascimento
    Eduarda da Costa Marinho
    Pollyana Júnia Felicidade
    Rafael Mathias Antonioli
    Rogério Agenor de Araújo
    Marcelo José Barbosa Silva
    Scientific Reports, 13
  • [45] Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis
    O'Keefe, Thomas J.
    Wallace, Anne M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (03) : 761 - 762
  • [46] The evolving presentation of renal carcinoma in the United States: Trends from the surveillance, epidemiology, and end results program
    Nguyen, Mike M.
    Gill, Inderbir S.
    Ellison, Lars M.
    JOURNAL OF UROLOGY, 2006, 176 (06): : 2397 - 2400
  • [47] Lung Cancer Survival in Younger Patients (<40 Years): Analysis of Surveillance, Epidemiology and End Results Program Data
    Bittoni, M.
    Fisher, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S776 - S777
  • [48] Recent trends in the characteristics of patients with distant stage breast cancer in the United States Surveillance, Epidemiology and End Stage Disease (SEER) program
    Li, J.
    Dalvi, T.
    Pawaskar, M.
    Tsai, K.
    Caspard, H.
    Fryzek, J.
    CANCER RESEARCH, 2012, 72
  • [49] Recent trends in incidence, survival and mortality of female breast in the US: A Surveillance, Epidemiology, and End Results (SEER) database study 2010-2020
    Asif, Samia
    Kesireddy, Meghana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka cancer registry, Japan surveillance, epidemiology and end results program, USA
    Yoshimi, I
    Ohshima, A
    Ajiki, W
    Tsukuma, H
    Sobue, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (02) : 98 - 104